Sutton Place Investors’s AbbVie ABBV Stock Holding History

Sutton Place Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300K	Sell	1,191 -11	-0.9%	-$2.37K	0.15%	113
2026 Q1	$261K	Sell	1,202 -7	-0.6%	-$1.55K	0.14%	113
2025 Q4	$276K	Buy	1,209 +61	+5%	+$13.9K	0.15%	109
2025 Q3	$266K	Buy	+1,148	New	+$234K	0.15%	108
2025 Q2	–	Sell	-1,084	Closed	-$227K	–	119
2025 Q1	$227K	Sell	1,084 -1,483	-58%	-$288K	0.15%	102
2024 Q4	$456K	Buy	2,567 +27	+1%	+$4.96K	0.26%	81
2024 Q3	$502K	Buy	2,540 +138	+6%	+$25.8K	0.31%	73
2024 Q2	$412K	Sell	2,402 -31	-1%	-$5.13K	0.27%	77
2024 Q1	$443K	Buy	+2,433	New	+$419K	0.22%	111

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sutton Place Investors's ABBV Position: Q2 2026 in Review

Sutton Place Investors reduced its AbbVie (ABBV) stake by 0.92% in Q2 2026, selling an estimated $2.37K and leaving 1,191 shares worth $300K. The position accounts for 0.15% of the portfolio, ranked #113.

Sutton Place Investors first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $502K in Q3 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sutton Place Investors held 1,191 shares of AbbVie worth $300K as of Q2 2026.
Sutton Place Investors sold 11 AbbVie shares in Q2 2026, an estimated $2.37K.
AbbVie made up 0.15% of Sutton Place Investors's portfolio in Q2 2026, its #113 holding.
Sutton Place Investors first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
Sutton Place Investors's AbbVie position peaked at $502K in Q3 2024.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sutton Place Investors's 13F filing for Q2 2026, filed 6 Aug 2026.